#Drug_Therapy

  1. Interpersonal sensitivity and response to selective serotonin reuptake inhibitors in patients with acute major depressive disorder
  2. Enhancing psychological interventions for post-traumatic stress disorder (PTSD) treatment with memory influencing drugs
  3. The efficacy of psychotherapies and pharmacotherapies for mental disorders in adults: An umbrella review and meta‐analytic evaluation of recent meta‐analyses
  4. Pharmacotherapy for PTSD
  5. Association between suicide death and concordance with benzodiazepine treatment guidelines for anxiety and sleep disorders
  6. How do we determine whether antidepressants are useful or not?
  7. Influence of baseline severity on the effects of SSRIs in depression: An item-based, patient-level post-hoc analysis
  8. Use of gabapentin in the treatment of substance use and psychiatric disorders: A systematic review
  9. Pharmacological therapy in panic disorder: Current guidelines and novel drugs discovery for treatment-resistant patient
  10. Early symptom non-improvement and aggravation are associated with the treatment response to SSRIs in MDD: A real-world study
  11. Great boast, small roast on effects of selective serotonin reuptake inhibitors: Response to a critique of our systematic review
  12. Efficacy of selective serotonin reuptake inhibitors and adverse events: Meta-regression and mediation analysis of placebo-controlled trials
  13. The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations
  14. Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: Results from the CO-MED trial
  15. Evidence-based somatic treatment of depression in adults
  16. Selective serotonin reuptake inhibitors for unipolar depression: A systematic review of classic long-term randomized controlled trials
  17. How often do SSRIs and other new-generation antidepressants lose their effect during continuation treatment? Evidence suggesting the rate of true tachyphylaxis during continuation treatment is low
  18. Publication bias in systematic reviews
  19. Early Onset of Selective Serotonin Reuptake Inhibitor Antidepressant Action
  20. Escitalopram maintenance treatment for prevention of recurrent depression: A randomized, placebo-controlled trial
  21. Two items on the Hamilton Depression rating scale are effective predictors of remission: Comparison of selective serotonin reuptake inhibitors with the combined serotonin/norepinephrine reuptake inhibitor, venlafaxine
  22. Fixed-dose trial of the single isomer SSRI Escitalopram in depressed outpatients
  23. Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo
  24. Efficacy of SSRIs and newer antidepressants in severe depression: Comparison with TCAs
  25. Placebo responses to antidepressants
  26. The treatment of severe depression: Is there an efficacy gap between SSRI and TCA antidepressant generations?
  27. 'Safety and antidepressant efficacy of selective serotonin re-uptake inhibitors': Erratum
  28. Placebo-controlled efficacy of antidepressants in continuation treatment
  29. Safety and antidepressant efficacy of selective serotonin re-uptake inhibitors
  30. Paroxetine: An overview of the efficacy and safety of a new selective serotonin reuptake inhibitor in the treatment of depression